Santiago Arroyo's most recent trade in Bicycle Therapeutics Plc - ADR was a trade of 87,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bicycle Therapeutics Plc -... | Santiago Arroyo | CHIEF DEVELOPMENT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 87,000 | 87,000 | - | - | Employee Stock Option (right to buy) | |
| Bicycle Therapeutics Plc -... | Santiago Arroyo | CHIEF DEVELOPMENT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 35,000 | 74,000 | - | 0 | Ordinary Shares | |
| Bicycle Therapeutics Plc -... | Santiago Arroyo | CHIEF DEVELOPMENT OFFICER | Sale of securities on an exchange or to another person at price $ 14.09 per share. | 02 Jan 2025 | 4,943 | 69,057 | - | 14.1 | 69,647 | Ordinary Shares |
| Bicycle Therapeutics Plc -... | Santiago Arroyo | CHIEF DEVELOPMENT OFFICER | 06 Feb 2024 | 41,570 | 41,570 | - | - | Employee Stock Option (right to buy) | ||
| Bicycle Therapeutics Plc -... | Santiago Arroyo | CHIEF DEVELOPMENT OFFICER | 06 Feb 2024 | 21,660 | 39,000 | - | 0 | Ordinary Shares | ||
| Bicycle Therapeutics Plc -... | Santiago Arroyo | Chief Development Officer | 02 Jan 2024 | 35,430 | 35,430 | - | - | Employee Stock Option (right to buy) | ||
| Bicycle Therapeutics Plc -... | Santiago Arroyo | Chief Development Officer | 02 Jan 2024 | 17,340 | 17,340 | - | 0 | Ordinary Shares | ||
| Marinus Pharmaceuticals Inc | Santiago Arroyo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 12,375 | 12,375 | - | - | Stock Option (Right to Buy) | |
| Marinus Pharmaceuticals Inc | Santiago Arroyo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 2,750 | 2,750 (0%) | 0% | 0 | Common Stock | |
| Marinus Pharmaceuticals Inc | Santiago Arroyo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 33,000 | 33,000 | - | - | Stock option (right to buy) |